Clinical experience with quetiapine, an atypical antipsychotic agent

被引:0
|
作者
Cantillon, M [1 ]
Arvanitis, LA [1 ]
机构
[1] ZENECA PHARMACEUT,CLIN RES,WILMINGTON,DE 19850
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:502 / 502
页数:1
相关论文
共 50 条
  • [41] Voltammetric Analysis of the Novel Atypical Antipsychotic Drug Quetiapine in Human Serum and Urine
    Sibel A. Ozkan
    Burcu Dogan
    Bengi Uslu
    Microchimica Acta, 2006, 153 : 27 - 35
  • [42] 'Seroquel' (quetiapine), a promising new antipsychotic agent: Overview of safety and tolerability
    Goldstein, JM
    Arvanitis, LA
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 197 - 197
  • [43] Clinical Pharmacokinetics of QuetiapineAn Atypical Antipsychotic
    C. Lindsay DeVane
    Charles B. Nemeroff
    Clinical Pharmacokinetics, 2001, 40 : 509 - 522
  • [44] Clinical profile of an atypical antipsychotic: Risperidone
    Davis, JM
    Chen, N
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 131S - 131S
  • [45] Atypical antipsychotic switching versus atypical antipsychotic combination in schizoaffective disorder - A clinical case
    Ballesteros, A.
    Cortes, B.
    Petcu, A.
    Montes, L.
    Jaimes, W.
    Inchausti, F.
    EUROPEAN PSYCHIATRY, 2016, 33 : S536 - S536
  • [46] Clinical profile of an atypical antipsychotic: Risperidone
    Davis, JM
    Chen, N
    SCHIZOPHRENIA BULLETIN, 2002, 28 (01) : 43 - 61
  • [47] Clinical considerations with atypical antipsychotic augmentation
    Gitlin, Michael J.
    CNS SPECTRUMS, 2007, 12 (12) : 13 - 15
  • [48] INITIAL AUSTRALIAN EXPERIENCE WITH THE ATYPICAL ANTIPSYCHOTIC CLOZAPINE
    KEKS, NA
    COPOLOV, DL
    JOHNSON, G
    MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (09) : 638 - 639
  • [49] THE BEHAVIORAL PHARMACOLOGY OF OLANZAPINE, A NOVEL ATYPICAL ANTIPSYCHOTIC AGENT
    MOORE, NA
    TYE, NC
    AXTON, MS
    RISIUS, FC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (02): : 545 - 551
  • [50] Aripiprazole, an atypical antipsychotic agent with a special action mechanism
    不详
    PSYCHOPHARMAKOTHERAPIE, 2004, 11 : 1 - 4